These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 29903849)

  • 1. Subcutaneous furosemide in patients with refractory heart failure.
    Lozano Bahamonde A; Escolar Pérez V; Laskibar Asua A; Rodríguez Rodríguez M; Murga Eizagaechevarria N
    BMJ Support Palliat Care; 2018 Sep; 8(3):354-355. PubMed ID: 29903849
    [No Abstract]   [Full Text] [Related]  

  • 2. Subcutaneous infusion of furosemide administered by elastomeric pumps for decompensated heart failure treatment: initial experience.
    Zatarain-Nicolás E; López-Díaz J; de la Fuente-Galán L; García-Pardo H; Recio-Platero A; San Román-Calvar JA
    Rev Esp Cardiol (Engl Ed); 2013 Dec; 66(12):1002-4. PubMed ID: 24774118
    [No Abstract]   [Full Text] [Related]  

  • 3. Home subcutaneous infusion of furosemide in advanced decompensated heart failure.
    Sancho-Zamora MA
    Rev Esp Cardiol (Engl Ed); 2014 Mar; 67(3):241-2. PubMed ID: 24774406
    [No Abstract]   [Full Text] [Related]  

  • 4. Home subcutaneous infusion of furosemide in advanced decompensated heart failure. Response.
    Zatarain-Nicolás E; de la Fuente-Galán L; San Román-Calvar JA
    Rev Esp Cardiol (Engl Ed); 2014 Mar; 67(3):242. PubMed ID: 24774407
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
    Licata G; Di Pasquale P; Parrinello G; Cardinale A; Scandurra A; Follone G; Argano C; Tuttolomondo A; Paterna S
    Am Heart J; 2003 Mar; 145(3):459-66. PubMed ID: 12660669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subcutaneous Furosemide in Patients With Refractory Heart Failure.
    Lozano Bahamonde A; Escolar Pérez V; Echebarria Chousa A; Azcona Lucio A; Alfambra Vicente S; Rodríguez Rodríguez B
    Rev Esp Cardiol (Engl Ed); 2019 Jun; 72(6):500-502. PubMed ID: 30029975
    [No Abstract]   [Full Text] [Related]  

  • 7. Outcomes of furosemide-mannitol infusion in hospitalized patients with heart failure: an observational single-center cohort study of 122 patients.
    Turagam MK; Velagapudi P; Kalra AS; Ramalingam VS; Sinnakirouchenan R; Holley JL
    Int J Cardiol; 2011 Sep; 151(2):232-4. PubMed ID: 21703703
    [No Abstract]   [Full Text] [Related]  

  • 8. Administration of Subcutaneous Furosemide in Elastomeric Pump vs. Oral Solution for the Treatment of Diuretic Refractory Congestion.
    López-Vilella R; Sánchez-Lázaro I; Husillos Tamarit I; Monte Boquet E; Núñez Villota J; Donoso Trenado V; Martínez Dolz L; Almenar Bonet L
    High Blood Press Cardiovasc Prev; 2021 Nov; 28(6):589-596. PubMed ID: 34596886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Palliative use of furosemide in continuous subcutaneous infusion in a renal transplant patient with heart failure.
    Picazo Sánchez M; Castillo Lorenzo MN; Cuxart Pérez M; Sans Lorman R
    Nefrologia (Engl Ed); 2018; 38(4):438-439. PubMed ID: 29275931
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as a bolus, in refractory congestive heart failure.
    Paterna S; Di Pasquale P; Parrinello G; Amato P; Cardinale A; Follone G; Giubilato A; Licata G
    Eur J Heart Fail; 2000 Sep; 2(3):305-13. PubMed ID: 10938493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subcutaneous furosemide for the treatment of heart failure: a state-of-the art review.
    Afari ME; Aoun J; Khare S; Tsao L
    Heart Fail Rev; 2019 May; 24(3):309-313. PubMed ID: 30617666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral metolazone plus frusemide for home therapy in patients with refractory heart failure.
    Lancet; 1989 Apr; 1(8640):727-8. PubMed ID: 2564538
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of salt with low-dose furosemide and carperitide for treating acute decompensated heart failure: a single-center retrospective cohort study.
    Okuhara Y; Hirotani S; Ando T; Nishimura K; Orihara Y; Komamura K; Naito Y; Mano T; Masuyama T
    Heart Vessels; 2017 Apr; 32(4):419-427. PubMed ID: 27469321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diuretic dose and long-term outcomes in elderly patients with heart failure after hospitalization.
    Abdel-Qadir HM; Tu JV; Yun L; Austin PC; Newton GE; Lee DS
    Am Heart J; 2010 Aug; 160(2):264-271.e1. PubMed ID: 20691831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subcutaneous furosemide patch: heart failure decongestion 'from the comfort of your home'.
    Dimitriadis K; Pyrpyris N; Tsioufis K
    Eur Heart J Cardiovasc Pharmacother; 2024 May; 10(3):259-260. PubMed ID: 38289722
    [No Abstract]   [Full Text] [Related]  

  • 16. Subcutaneous furosemide.
    Goenaga MA; Millet M; Sánchez E; Garde C; Carrera JA; Arzellus E
    Ann Pharmacother; 2004 Oct; 38(10):1751. PubMed ID: 15340122
    [No Abstract]   [Full Text] [Related]  

  • 17. Assessing parenteral diuretic treatment of decompensated heart failure in the community.
    Austin J; Hockey D; Williams WR; Hutchison S
    Br J Community Nurs; 2013 Nov; 18(11):528, 530-4. PubMed ID: 24471224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic implications of outpatient diuretic dose in heart failure.
    Harjai KJ; Dinshaw HK; Nunez E; Shah M; Thompson H; Turgut T; Ventura HO
    Int J Cardiol; 1999 Dec; 71(3):219-25. PubMed ID: 10636527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is there a role for subcutaneous furosemide in the community and hospice management of end-stage heart failure?
    Zacharias H; Raw J; Nunn A; Parsons S; Johnson M
    Palliat Med; 2011 Sep; 25(6):658-63. PubMed ID: 21398345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal function on admission modifies prognostic impact of diuretics in acute heart failure: a propensity score matched and interaction analysis.
    Matsue Y; Shiraishi A; Kagiyama N; Yoshida K; Kume T; Okura H; Suzuki M; Matsumura A; Yoshida K; Hashimoto Y
    Heart Vessels; 2016 Dec; 31(12):1980-1987. PubMed ID: 26892531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.